ArentFox Schiff Partner Elizabeth H. Cohen spoke with Managing IP about the recent federal circuit ruling in the '.SUCKS' trademark battle.
Arent Fox's Pamela Deese spoke with Licensing International about the metaverse forcing brands to stake new trademark claims to ward off would-be infringers.
Partner David Loring was quoted on the Biden Administration and U.S. Environmental Protection Agency’s (EPA) restoration of the “appropriate and necessary” finding that provides the legal basis for Mercury and Air Toxics Standards.
Arent Fox Fintech Industry Group Co-Leader Jenny Lee spoke with American Banker about the review of fees charged by banks, credit unions, mortgage lenders, and fintechs as part of an effort to spur more competition for financial services.
Arent Fox partner Jenny Lee was quoted in an article in Bloomberg Law regarding the California Department of Financial Protection and Innovation’s (DFPI) role in leading a recent enforcement action brought by 42 state regulatory agencies.
Health Care Practice Group Partner Rachel Hold-Weiss was recently quoted in a McKnights article.
Partner Kevin Nelson was quoted on a Federal Circuit Court ruling in GlaxoSmithKline v. Teva, which has caused concern among some generic drug manufacturers regarding their ability to sell generic drugs that leave patent-protected uses off the label.
Partner Bina Joshi was quoted on the proposed rule from the Illinois Environmental Protection Agency setting groundwater standards for per- and polyfluoroalkyl substances (PFAS).Bloomberg Law
Intellectual Property Practice Group Co-Leader Imron Aly was interviewed and quoted regarding leading patent law issues published in a Bloomberg report.
Partner Jane Montgomery was quoted on the US Supreme Court’s decision to hear arguments in a significant climate change case that could limit EPA’s ability to require systemwide emissions reductions measures for power plants, and impact federal agency authority over statutes like the Clean AE&E News
Intellectual Property Practice Group Co-Leader Sailesh Patel was quoted on the patent litigation trends to watch for in 2022, including the uptick in patent owners looking to litigation funding businesses.
Managing Partner Joseph Krasovec was featured in a video among Big Law decision-makers about the future of in-office life in the legal industry.
The scope of the federal Clean Water Act (CWA) is in flux yet again. Recently, in Pasqua Yaqui Tribe v. EPA, the U.S. District Court for the District of Arizona vacated and remanded a Trump-era regulation that defined the scope of many CWA programs.
Illinois lawyers in all practice areas can benefit from a basic understanding of federal and state environmental laws to help identify environmental obligations and address the concerns of the clients they serve.
Plant-based products and alternatives to “traditional” dairy and meat-based proteins have become ubiquitous in our supermarkets and restaurants.
The Canada Border Services Agency (CBSA) has intercepted a shipment of women's and children's clothing from China that it suspects of being manufactured, in whole, or in part, using forced labor.
After completing ROTC at Bucknell University, Matthew Wilkerson was commissioned as a Second Lieutenant in the U.S. Army Reserve (USAR) Medical Service Corps.
In 2010, James Cromley followed in his father’s footsteps and joined the United States Marine Corps.
Amy Antoniolli was quoted on how fund management firms, banks, and broker-dealers can approach their vendors regarding their environmental, social, and governance (ESG) policies.
Arent Fox Firmwide Managing Partner Cristina A. Carvalho has once again been selected by Washingtonian magazine as one of the "Most Powerful Women in Washington."
Schiff Hardin attorneys Joel Wallace and Helen Ji have been recognized as 2021 Rising Starts by Managing Intellectual Property. This is Helen’s second year of recognition and Joel’s first year.
Partner Imron Aly was quoted regarding a letter from the U.S. Food and Drug Administration (FDA) sent to the U.S. Patent and Trademark Office (USPTO) with suggestions on how to prevent some patent-owning pharmaceutical companies from blocking generics from entering the market.